238 related articles for article (PubMed ID: 17183249)
1. Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells.
Disthabanchong S; Radinahamed P; Stitchantrakul W; Hongeng S; Rajatanavin R
Kidney Int; 2007 Feb; 71(3):201-9. PubMed ID: 17183249
[TBL] [Abstract][Full Text] [Related]
2. Osteocalcin Mediates Biomineralization during Osteogenic Maturation in Human Mesenchymal Stromal Cells.
Tsao YT; Huang YJ; Wu HH; Liu YA; Liu YS; Lee OK
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106724
[TBL] [Abstract][Full Text] [Related]
3. Alteration of noncollagenous bone matrix proteins in distal renal tubular acidosis.
Disthabanchong S; Domrongkitchaiporn S; Sirikulchayanonta V; Stitchantrakul W; Karnsombut P; Rajatanavin R
Bone; 2004 Sep; 35(3):604-13. PubMed ID: 15336595
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell.
Sila-Asna M; Bunyaratvej A; Maeda S; Kitaguchi H; Bunyaratavej N
Kobe J Med Sci; 2007; 53(1-2):25-35. PubMed ID: 17579299
[TBL] [Abstract][Full Text] [Related]
5. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization.
Brandao-Burch A; Utting JC; Orriss IR; Arnett TR
Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362
[TBL] [Abstract][Full Text] [Related]
6. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
7. Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling.
Wang G; Zhang X; Yu B; Ren K
Mol Med Rep; 2015 Jul; 12(1):877-84. PubMed ID: 25816130
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans enhance osteoblast differentiation of bone marrow derived human mesenchymal stem cells.
Mathews S; Mathew SA; Gupta PK; Bhonde R; Totey S
J Tissue Eng Regen Med; 2014 Feb; 8(2):143-52. PubMed ID: 22499338
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
[TBL] [Abstract][Full Text] [Related]
10. Short-term moderate hypothermia stimulates alkaline phosphatase activity and osteocalcin expression in osteoblasts by upregulating Runx2 and osterix in vitro.
Aisha MD; Nor-Ashikin MN; Sharaniza AB; Nawawi HM; Kapitonova MY; Froemming GR
Exp Cell Res; 2014 Aug; 326(1):46-56. PubMed ID: 24928274
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
[TBL] [Abstract][Full Text] [Related]
12. The Role of KV7.3 in Regulating Osteoblast Maturation and Mineralization.
Yang JE; Song MS; Shen Y; Ryu PD; Lee SY
Int J Mol Sci; 2016 Mar; 17(3):407. PubMed ID: 26999128
[TBL] [Abstract][Full Text] [Related]
13. Conditioned medium from bone marrow mesenchymal stem cells transiently retards osteoblast differentiation by downregulating runx2.
Sun J; Zhou H; Deng Y; Zhang Y; Gu P; Ge S; Fan X
Cells Tissues Organs; 2012; 196(6):510-22. PubMed ID: 22906827
[TBL] [Abstract][Full Text] [Related]
14. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the osteogenic differentiation of human mesenchymal stromal cells by the synergistic action of growth factors.
Açil Y; Ghoniem AA; Wiltfang J; Gierloff M
J Craniomaxillofac Surg; 2014 Dec; 42(8):2002-9. PubMed ID: 25458345
[TBL] [Abstract][Full Text] [Related]
16. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
[TBL] [Abstract][Full Text] [Related]
17. JNK activity is essential for Atf4 expression and late-stage osteoblast differentiation.
Matsuguchi T; Chiba N; Bandow K; Kakimoto K; Masuda A; Ohnishi T
J Bone Miner Res; 2009 Mar; 24(3):398-410. PubMed ID: 19016586
[TBL] [Abstract][Full Text] [Related]
18. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
[TBL] [Abstract][Full Text] [Related]
19. The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation.
Liu Y; Bhat RA; Seestaller-Wehr LM; Fukayama S; Mangine A; Moran RA; Komm BS; Bodine PV; Billiard J
Mol Endocrinol; 2007 Feb; 21(2):376-87. PubMed ID: 17095577
[TBL] [Abstract][Full Text] [Related]
20. Aesculetin Accelerates Osteoblast Differentiation and Matrix-Vesicle-Mediated Mineralization.
Na W; Kang MK; Park SH; Kim DY; Oh SY; Oh MS; Park S; Kang IJ; Kang YH
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
